In the SURPASS-2 trial published in the New England Journal of Medicine, tirzepatide at 15 mg produced an average weight loss of 11.2 kg compared to 5.7 kg with semaglutide 1 mg over 40 weeks
[DOI] [PMC free article] [PubMed] [Google Scholar] 140.Araj-Khodaei M., Ayati M.H., Zeinalhajlou A.A., Novinbahador T., Yousefi M., Shiri M., Mahmoodpoor A., Shamekh A., Namazi N., Sanaie S
Our compounded Semaglutide not only mirrors the effects of traditional Semaglutide but also includes body-safe vitamins like B6, B12, and L-Carnitine
As more younger adults are being treated with therapies that have been inadequately studied in pregnancy, it is essential to describe the reproductive safety of recommended approaches